Tuesday 10 April 2012, Amsterdam
The report provides market landscape, competitive landscape and market trends information on eight anesthesia and respiratory devices market categories – anesthesia machines, pain management devices, regional anesthesia disposables, respiratory devices, respiratory disposables, respiratory measurement devices, sleep apnea diagnostic systems and airway anesthesia devices. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, with analysis of major mergers and acquisitions (M&A) in the last four years and a detailed analysis of the pipeline products in each category.
The Global Anesthesia and Respiratory Devices Market to Exceed $14 billion by 2017
See figure: Anesthesia and Respiratory Devices, Global, Overall Revenues ($bn), 2010 – 2017
The global anesthesia and respiratory devices market is forecast to exceed $14 billion by 2017 with a Compound Annual Growth Rate (CAGR) of 4.7% during the period 2010-2017. The market is expected to be primarily driven by the huge patient population suffering from respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) and the availability of medical devices to treat Obstructive Sleep Apnea (OSA) and COPD. Globally, about 300 million people suffer from OSA, the prevalence of which increases with age, reaching 30% to 80% in the elderly population. Similarly, the prevalence of COPD is high and currently about 400 to 600 million people suffer from COPD on a global basis, with about 12 million patients in the US. This provides good opportunites for growth for the medical device companies. Other factors to drive the growth of the anesthesia and respiratory devices market include, an increase in disposable income in emerging countries, an increase in the number of hospitals, growing demand for h
me healthcare devices and an expansion in reimbursement for wide range of anesthesia and respiratory devices.
Covidien, Phillips Respironics, Resmed and Draegerwerk AG are the Leading Companies in the Anesthesia and Respiratory Devices Market
In 2010, Covidien, Phillips Respironics, Resmed and Draegerwerk were the leading players in the anesthesia and respiratory devices market, with a combined market share of 33%. Draegerwerk AG & Co. and GE Healthcare dominate the market for anesthesia machines. Philips Respironics is one of the leading players in the respiratory devices market and Covidien is the market leader in the respiratory measurement devices market. The reasons why these companies dominate is their long-term presence in the healthcare market, the relationships they have developed with hospitals and physicians over a period of time and the brand name recognition they enjoy with patients.
Development of Home Settings for Healthcare Delivery to Continue in Future
The shift of healthcare delivery from hospitals to home care is one of the most significant trends in health care industry today. Many factors have contributed to this shift, including technological advancements, changing demographics and government initiatives to reduce healthcare expenditure.
In order to meet the growing need of home healthcare products the availability of such home products has increased. The home care devices range from patient monitors, glucose meters and ventilators to advanced-technology infusion, dialysis, and respiration devices.
Continuous innovation in design and technology has led to user-friendly devices which can be used by patients without disturbing their normal routine and are increasingly being adopted by patients worldwide.
For respiratory disorders, demand for compact, lightweight, quiet and portable hand–held nebulizers is increasing around the world. Various advancements in design and technology have led to the introduction of user-friendly home healthcare equipment, which in turn has resulted in an increase in the adoption rates of these devices worldwide and this is expected to continue in future.
The demand for home healthcare equipment will have a positive impact on the growth of the respiratory devices category of the anesthesia and respiratory devices market due to the availability of a range of respiratory devices such as portable nebulizers and Continous Positive Air Pressure (CPAP) and Bilevel Positive Air Pressure (BiPAP) machines which are designed for use at home.
Integration of Anesthesia and Respiratory Devices With the Hospital Information Systems Leading to Better Connectivity and Productivity is Driving the Growth of the Market
The integration of anesthesia and respiratory devices with hospital information systems solved the problem of connectivity for data data management and has resulted in an increase in the usage of these devices, thereby driving the growth of the overall market.
The anesthesia and respiratory care devices management information systems offer many advantages over paper-based systems. The medical records of the patients are transferred automatically to their Electronic Medical Records (EMR), eliminating the need for manual entry. Information technology thus plays an important role in the timely collection, recording, analysis and reporting of clinical data. The automation of the whole process leads to increased productivity.
In the case of anesthesia care, the identification of key information quickly and easily is critical to anesthesia delivery practice, and this has increased the importance of information systems which can quuickly record and retrieve this data.
The growing need for fast data flow in hospitals for information recording, clinical data analysis and timely delivery of results has led to the application of information technology, which has enabled the connectivity of most of the anesthesia and respiratory devices, such as anesthesia machines, pulse oximeter systems and respiratory devices with the hospital information system. For example, Siemens Healthcare introduced Centricity Anaesthesia, which is an advanced clinical information management system designed for anaesthesia. Such devices enable real time data transfer to the physicians facilitating timely and better treatment.
This results in improved satisfaction for both physicians and patients, thereby driving the overall growth of the anesthesia and respiratory devices market.
Centralized anesthesia and respiratory care data management is a very efficient and cost-effective way to monitor patients and manage the hospital-wide allocation of anesthesia and respiratory care services. This will result in an increase in the adoption rate of anesthesia and respiratory care devices, leading to a growth of the market.
